A Structural Characterisation of the Mitogen-Activated Protein Kinase Network in Cancer

被引:1
|
作者
Chatzaroulas, Evangelos [1 ]
Sliogeris, Vytenis [1 ]
Victori, Pedro [2 ]
Buffa, Francesca M. [2 ]
Moschoyiannis, Sotiris [1 ]
Bauer, Roman [1 ]
机构
[1] Univ Surrey, Sch Comp Sci & Elect Engn, Guildford GU2 7XH, Surrey, England
[2] Univ Oxford, Dept Oncol, Med Sci Div, Computat Biol & Integrat Genom Lab, Oxford OX3 7DQ, England
来源
SYMMETRY-BASEL | 2022年 / 14卷 / 05期
基金
欧洲研究理事会; “创新英国”项目; 英国工程与自然科学研究理事会;
关键词
cancer; hallmarks; complex networks; network analysis; RICH-CLUB; HALLMARKS; EVOLUTION; PATHWAYS; TOPOLOGY; JNK;
D O I
10.3390/sym14051009
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Gene regulatory networks represent collections of regulators that interact with each other and with other molecules to govern gene expression. Biological signalling networks model how signals are transmitted and how activities are coordinated in the cell. The study of the structure of such networks in complex diseases such as cancer can provide insights into how they function, and consequently, suggest suitable treatment approaches. Here, we explored such topological characteristics in the example of a mitogen-activated protein kinase (MAPK) signalling network derived from published studies in cancer. We employed well-established techniques to conduct network analyses, and collected information on gene function as obtained from large-scale public databases. This allowed us to map topological and functional relationships, and build hypotheses on this network's functional consequences. In particular, we find that the topology of this MAPK network is highly non-random, modular and robust. Moreover, analysis of the network's structure indicates the presence of organisational features of cancer hallmarks, expressed in an asymmetrical manner across communities of the network. Finally, our results indicate that the organisation of this network renders it problematic to use treatment approaches that focus on a single target. Our analysis suggests that multi-target attacks in a well-orchestrated manner are required to alter how the network functions. Overall, we propose that complex network analyses combined with pharmacological insights will help inform on future treatment strategies, exploiting structural vulnerabilities of signalling and regulatory networks in cancer.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Mitogen-Activated Protein Kinase Kinase 4 Gene Polymorphism and Cancer Risk
    Geng, Peiliang
    Ou, Juanjuan
    Xie, Ganfeng
    Li, Jianjun
    Zhao, Xiaoxin
    Xiang, Lisha
    Liao, Yunmei
    Wang, Ning
    Liang, Houjie
    [J]. MEDICINE, 2015, 94 (44) : e938
  • [22] Mitogen-activated protein kinase kinase 7 in inflammatory, cancer, and neurological diseases
    Caliz, Amada D.
    Vertii, Anastassiia
    Fisch, Vijay
    Yoon, Soonsang
    Yoo, Hyung-Jin
    Keaney Jr, John F.
    Kant, Shashi
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [23] Regulation of mitogen-activated protein kinase by protein kinase C and mitogen-activated protein kinase phosphatase-1 in vascular smooth muscle
    Trappanese, Danielle M.
    Sivilich, Sarah
    Ets, Hillevi K.
    Kako, Farah
    Autieri, Michael V.
    Moreland, Robert S.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2016, 310 (11): : C921 - C930
  • [24] Discovery of a mitogen-activated protein kinase regulator in Pneumocystis carinii.: Sequencing the gene for mitogen-activated protein kinase kinase kinase.
    Park, JG
    Puri, V
    Kottom, TJ
    Thomas, CF
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2000, 48 (05) : 243A - 243A
  • [25] Redox-dependent dimerization of p38α mitogen-activated protein kinase with mitogen-activated protein kinase kinase 3
    Bassi, Rekha
    Burgoyne, Joseph R.
    DeNicola, Gian F.
    Rudyk, Olena
    DeSantis, Vittorio
    Charles, Rebecca L.
    Eaton, Philip
    Marber, Michael S.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (39) : 16161 - 16173
  • [26] Cilia and mitogen-activated protein kinase signaling
    Jivan, Arif
    Earnest, Svetlana
    Cobb, Melanie H.
    [J]. FASEB JOURNAL, 2008, 22
  • [27] Inhibition of the mitogen-activated protein kinase pathways
    Murray, K
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1997, 122 : P177 - P177
  • [28] Mitogen-activated protein kinase in human eggs
    Sun, QY
    Blumenfeld, Z
    Rubinstein, S
    Goldman, S
    Gonen, Y
    Breitbart, H
    [J]. ZYGOTE, 1999, 7 (02) : 181 - 185
  • [29] The plant mitogen-activated protein (MAP) kinase
    Liu, Q
    Zhang, GY
    Shinozaki, K
    [J]. ACTA BOTANICA SINICA, 2000, 42 (07): : 661 - 667
  • [30] Distinct Genetic Alterations in the Mitogen-Activated Protein Kinase Pathway Dictate Sensitivity of Thyroid Cancer Cells to Mitogen-Activated Protein Kinase Kinase 1/2 Inhibition
    Schweppe, Rebecca E.
    Kerege, Anna A.
    Sharma, Vibha
    Poczobutt, Joanna M.
    Gutierrez-Hartmann, Arthur
    Grzywa, Rachel L.
    Haugen, Bryan R.
    [J]. THYROID, 2009, 19 (08) : 825 - 835